Village Integrated Eye Workers Trial
村综合眼科工作者试验
基本信息
- 批准号:9335362
- 负责人:
- 金额:$ 17.85万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2013
- 资助国家:美国
- 起止时间:2013-09-30 至 2019-08-31
- 项目状态:已结题
- 来源:
- 关键词:AddressAfricaAnti-Bacterial AgentsAntibiotic ProphylaxisAntibioticsAntifungal AgentsAreaAsiaBhutanBlindnessCaliforniaCensusesChloramphenicolCicatrixClinicClinicalClinical TrialsCollaborationsCommunitiesCommunity HealthCommunity OutreachCorneaCorneal AbrasionCorneal DiseasesCorneal OpacityCorneal UlcerCost AnalysisDeveloping CountriesDiagnosisEpidemiologyEthicsEyeEye diseasesHarvestHealth PromotionHealth StatusHealth care facilityHealthcareHospitalsHourIncidenceIncidence StudyIndiaInfectionInterventionKeratitisLeprosyLogisticsMasksMeasuresMethodsMonitorMorbidity - disease rateMyanmarMycosesNepalOintmentsOnchocerciasisOutcomePatientsPersonsPoliciesPopulationPreventionPrevention programPreventive InterventionProphylactic treatmentProspective cohort studyRandomizedRandomized Clinical TrialsRandomized Controlled TrialsRecording of previous eventsResearchResearch InfrastructureResolutionRuralRural CommunitySan FranciscoSeasonsServicesSurveysTrachomaTrainingTreatment EfficacyUlcerUnited StatesUniversitiesVillage Health WorkersVisionVisitVisualVisual impairmentWagesantimicrobialblindcostcost effectivecost effectivenesseffective interventionevidence baseimprovedmicrobialpopulation basedpreventprimary outcomeprogramspublic health relevancerandomized trialscale upstandard of caretopical antibacterialtreatment programtrial comparinguptakevolunteer
项目摘要
DESCRIPTION (provided by applicant): The objective of this study is to assess the efficacy of antibiotic ointment prophylaxis to reduce incidence of corneal ulceration and subsequent blindness. We compare communities randomized to receive an intensive health promotion effort aimed at early prophylaxis for corneal abrasion to communities receiving standard-of care (no active intervention). Corneal ulceration is a leading cause of blindness globally, and once infection is present it is difficult to substantially improve visual potential of the eye. Individully randomized controlled trials have been unsuccessful at demonstrating large differences in clinical outcomes with different antimicrobial or adjunctive therapies. Prospective cohort studies have suggested that antibiotic prophylaxis
Is effective at reducing corneal ulceration, but a community randomized clinical trial is necessary to provide definitive evidence of the efficacy of interventions with antibiotic prophylaxis at the community level. We expect that this study will provide an evidence base for such an intervention through the following specific aims: 1) to determine if antibiotic prophylaxis
after corneal abrasion reduces the incidence of corneal ulceration in a community randomized trial. 2) To assess the costs and cost-effectiveness of a preventative intervention for microbial keratitis. 3) To determine the incidence of corneal ulceration and abrasion in this district of Taml Nadu, India. No community-randomized trial has ever been performed for microbial keratitis. These trials are difficult to conduct, because of infrastructure and logistical requirements as wel as ethical considerations. We address this by building on our collaborations between the University of California, San Francisco and the Aravind Eye Hospital in Madurai, India. Aravind has an existing infrastructure of community outreach and vision centers that will allow for this study to be completed at a large scale. Patients in control communities will receive treatment should they seek it, as it would be unethical not to provide treatment, but these communities will not receive active health promotion activities. If proven to be effective, this study will provide definitive evidence on a cost-effective, scalable intervention that could substantially reduce the burden of blindness particularly in rural communities in the developing world.
描述(由申请人提供):本研究的目的是评估抗生素软膏预防对减少角膜溃疡和随后失明发生率的疗效。我们将随机接受旨在早期预防角膜磨损的强化健康促进措施的社区与接受标准护理(无主动干预)的社区进行比较。角膜溃疡是全球致盲的主要原因,一旦感染,就很难实质性地改善眼睛的视觉潜力。个体随机对照试验未能证明不同抗菌素或辅助治疗在临床结果上的巨大差异。前瞻性队列研究表明,抗生素预防
项目成果
期刊论文数量(6)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Risk factors for corneal abrasions in Nepal: a community-based study.
尼泊尔角膜擦伤的危险因素:一项基于社区的研究。
- DOI:10.1038/s41433-023-02809-0
- 发表时间:2024
- 期刊:
- 影响因子:0
- 作者:Brekke,SylviaR;Giri,Puspa;Byanju,Raghunandan;Pradhan,Sangita;Bhandari,Gopal;Bhandari,Sadhan;Kandel,RamPrasad;Poudyal,Bimal;Gonzales,JohnA;Srinivasan,Muthiah;Upadhyay,Madan;Whitcher,JohnP;O'Brien,KieranS;Lietman,ThomasM;Ke
- 通讯作者:Ke
Smartphone-based Anterior Segment Imaging: A Comparative Diagnostic Accuracy Study of a Potential Tool for Blindness Prevalence Surveys.
基于智能手机的眼前段成像:失明患病率调查潜在工具的比较诊断准确性研究。
- DOI:10.1080/09286586.2021.1980589
- 发表时间:2022-10
- 期刊:
- 影响因子:1.8
- 作者:Kumar A;Ali FS;Stevens VM;Melo JS;Venkatesh Prajna N;Lalitha P;Srinivasan M;Bhandari G;Bhandari S;Maamari RN;Fletcher DA;Lietman TM;Keenan JD
- 通讯作者:Keenan JD
Community Health Workers for Prevention of Corneal Ulcers in South India: A Cluster-Randomized Trial.
- DOI:10.1016/j.ajo.2021.12.010
- 发表时间:2022-05
- 期刊:
- 影响因子:4.2
- 作者:Srinivasan, Muthiah;Ravilla, Thulasiraj;Vijayakumar, Valaguru;Yesunesan, Devanesam;Mani, Iswarya;Whitcher, John P.;Oldenburg, Catherine E.;O'brien, Kieran S.;Lietman, Thomas M.;Keenan, Jeremy D.
- 通讯作者:Keenan, Jeremy D.
Village-integrated eye workers for prevention of corneal ulcers in Nepal (VIEW study): a cluster-randomised controlled trial.
- DOI:10.1016/s2214-109x(21)00596-9
- 发表时间:2022-04
- 期刊:
- 影响因子:34.3
- 作者:O'Brien, Kieran S.;Byanju, Raghunandan;Kandel, Ram P.;Poudyal, Bimal;Gonzales, John A.;Porco, Travis C.;Whitcher, John P.;Srinivasan, Muthiah;Upadhyay, Madan;Lietman, Thomas M.;Keenan, Jeremy D.
- 通讯作者:Keenan, Jeremy D.
Risk factors for corneal ulcers: a population-based matched case-control study in Nepal.
角膜溃疡的危险因素:尼泊尔一项基于人群的匹配病例对照研究。
- DOI:10.1136/bjo-2022-322141
- 发表时间:2023
- 期刊:
- 影响因子:0
- 作者:Byanju,Raghunandan;Kandel,RamPrasad;Poudyal,Bimal;Bhandari,Sadhan;Ligal,Anju;Pradhan,Sangita;Gautam,Maria;Shrestha,Puspa;Sah,RanjeetKumar;Gonzales,JohnA;Porco,TravisC;Whitcher,JohnP;Srinivasan,Muthiah;Upadhyay,MadanPrasad;
- 通讯作者:
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
THOMAS M LIETMAN其他文献
THOMAS M LIETMAN的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('THOMAS M LIETMAN', 18)}}的其他基金
Azithromycin Reduction to Reach Elimination of Trachoma
减少阿奇霉素以消除沙眼
- 批准号:
10439385 - 财政年份:2020
- 资助金额:
$ 17.85万 - 项目类别:
Azithromycin Reduction to Reach Elimination of Trachoma
减少阿奇霉素以消除沙眼
- 批准号:
10616840 - 财政年份:2020
- 资助金额:
$ 17.85万 - 项目类别:
Azithromycin Reduction to Reach Elimination of Trachoma
减少阿奇霉素以消除沙眼
- 批准号:
10397057 - 财政年份:2020
- 资助金额:
$ 17.85万 - 项目类别:
UCSF-Proctor Clinician Vision Scholars K12 Program
UCSF-Proctor 临床医生视力学者 K12 计划
- 批准号:
10610924 - 财政年份:2020
- 资助金额:
$ 17.85万 - 项目类别:
UCSF-Proctor Clinician Vision Scholars K12 Program
UCSF-Proctor 临床医生视力学者 K12 计划
- 批准号:
10409646 - 财政年份:2020
- 资助金额:
$ 17.85万 - 项目类别:
Azithromycin Reduction to Reach Elimination of Trachoma
减少阿奇霉素以消除沙眼
- 批准号:
10907941 - 财政年份:2020
- 资助金额:
$ 17.85万 - 项目类别:
Azithromycin Reduction to Reach Elimination of Trachoma
减少阿奇霉素以消除沙眼
- 批准号:
10618166 - 财政年份:2020
- 资助金额:
$ 17.85万 - 项目类别:
Steroids and Cross-linking for Ulcer Treatment (SCUT II)
类固醇和交联治疗溃疡 (SCUT II)
- 批准号:
10397960 - 财政年份:2019
- 资助金额:
$ 17.85万 - 项目类别:
Steroids and Cross-linking for Ulcer Treatment (SCUT II)
类固醇和交联治疗溃疡 (SCUT II)
- 批准号:
10457913 - 财政年份:2019
- 资助金额:
$ 17.85万 - 项目类别:
Steroids and Cross-linking for Ulcer Treatment (SCUT II)
类固醇和交联治疗溃疡 (SCUT II)
- 批准号:
10222699 - 财政年份:2019
- 资助金额:
$ 17.85万 - 项目类别:
相似海外基金
Multi-component interventions to reducing unhealthy diets and physical inactivity among adolescents and youth in sub-Saharan Africa (Generation H)
采取多方干预措施减少撒哈拉以南非洲青少年的不健康饮食和缺乏身体活动(H 代)
- 批准号:
10106976 - 财政年份:2024
- 资助金额:
$ 17.85万 - 项目类别:
EU-Funded
Exploring the mental health and wellbeing of adolescent parent families affected by HIV in South Africa
探讨南非受艾滋病毒影响的青少年父母家庭的心理健康和福祉
- 批准号:
ES/Y00860X/1 - 财政年份:2024
- 资助金额:
$ 17.85万 - 项目类别:
Fellowship
Decolonization, Appropriation and the Materials of Literature in Africa and its Diaspora
非洲及其侨民的非殖民化、挪用和文学材料
- 批准号:
EP/Y024516/1 - 财政年份:2024
- 资助金额:
$ 17.85万 - 项目类别:
Research Grant
Exploring "Actionable Information" for Learning Improvement in Rural East Africa: A Positive Deviance Approach
探索东非农村地区学习改进的“可行信息”:积极偏差方法
- 批准号:
24K00390 - 财政年份:2024
- 资助金额:
$ 17.85万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
ePowerCart - Affordable Mobile Clean Energy for Remote Communities in Rural Sub-Saharan Africa and India
ePowerCart - 为撒哈拉以南非洲和印度农村偏远社区提供经济实惠的移动清洁能源
- 批准号:
10076185 - 财政年份:2024
- 资助金额:
$ 17.85万 - 项目类别:
Collaborative R&D
Protecting Women from Economic shocks to fight HIV in Africa (POWER)
保护非洲妇女免受经济冲击,抗击艾滋病毒 (POWER)
- 批准号:
MR/Y003837/1 - 财政年份:2024
- 资助金额:
$ 17.85万 - 项目类别:
Fellowship
Tackling antimicrobial resistance across dentistry in Sub-Saharan Africa.
解决撒哈拉以南非洲牙科领域的抗菌素耐药性问题。
- 批准号:
MR/Y019695/1 - 财政年份:2024
- 资助金额:
$ 17.85万 - 项目类别:
Research Grant
Water stressed cities: individual choice, access to water and pathways to resilience in sub-Saharan Africa
缺水城市:撒哈拉以南非洲地区的个人选择、水资源获取和恢复力途径
- 批准号:
MR/X022943/1 - 财政年份:2024
- 资助金额:
$ 17.85万 - 项目类别:
Fellowship
The Open fracture National Evaluation (ONE) Study - South Africa: Improving outcomes in the care of open fractures in low resource settings
开放性骨折国家评估 (ONE) 研究 - 南非:改善资源匮乏地区开放性骨折的护理效果
- 批准号:
MR/Y00955X/1 - 财政年份:2024
- 资助金额:
$ 17.85万 - 项目类别:
Fellowship
Recognising & supporting informal mhealth in Africa through grassroots interventions (REIMAGINE)
认识
- 批准号:
MR/Y015614/1 - 财政年份:2024
- 资助金额:
$ 17.85万 - 项目类别:
Research Grant














{{item.name}}会员




